{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T06:14:33Z","timestamp":1762841673927,"version":"build-2065373602"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"GSBTM","award":["GSBTM\/JDR&D\/608\/2020\/446-447"],"award-info":[{"award-number":["GSBTM\/JDR&D\/608\/2020\/446-447"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Netw Model Anal Health Inform Bioinforma"],"DOI":"10.1007\/s13721-025-00637-8","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T06:11:30Z","timestamp":1762841490000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Unveiling the radiotherapeutic role of Andrographolide and Melatonin in triple-negative breast cancer: a combined in silico and in vitro analysis"],"prefix":"10.1007","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4818-1376","authenticated-orcid":false,"given":"Devashish","family":"Mehta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8700-9929","authenticated-orcid":false,"given":"Jignesh","family":"Prajapati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3438-8405","authenticated-orcid":false,"given":"Kinjal","family":"Bhadresha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kinjal","family":"Jani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7985-1187","authenticated-orcid":false,"given":"Rakesh M.","family":"Rawal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,11]]},"reference":[{"key":"637_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-022-08927-x","author":"A Afaya","year":"2022","unstructured":"Afaya A, Ramazanu S, Bolarinwa OA (2022) Health system barriers influencing timely breast cancer diagnosis and treatment among women in low and middle-income Asian countries: evidence from a mixed-methods systematic review. BMC Health Serv Res. https:\/\/doi.org\/10.1186\/s12913-022-08927-x","journal-title":"BMC Health Serv Res"},{"key":"637_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.752270","author":"A Aranza-Mart\u00ednez","year":"2021","unstructured":"Aranza-Mart\u00ednez A, S\u00e1nchez-P\u00e9rez J, Brito-Elias L et al (2021) Non-coding RNAs associated with radioresistance in triple-negative breast cancer. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2021.752270","journal-title":"Front Oncol"},{"key":"637_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.breast.2022.08.010","volume":"66","author":"M Arnold","year":"2022","unstructured":"Arnold M, Morgan E, Rumgay H (2022) Current and future burden of breast cancer: global statistics for 2020 and 2040. Breast 66:15\u201323. https:\/\/doi.org\/10.1016\/j.breast.2022.08.010","journal-title":"Breast"},{"key":"637_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202102658","author":"X Bai","year":"2021","unstructured":"Bai X, Ni J, Beretov J (2021) THOC2 and THOC5 regulate stemness and radioresistance in triple-negative breast cancer. Adv Sci. https:\/\/doi.org\/10.1002\/advs.202102658","journal-title":"Adv Sci"},{"key":"637_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.173919","author":"V Banerjee","year":"2021","unstructured":"Banerjee V, Sharda N, Huse J et al (2021) Synergistic potential of dual Andrographolide and melatonin targeting of metastatic colon cancer cells: using the Chou-Talalay combination index method. Eur J Pharmacol. https:\/\/doi.org\/10.1016\/j.ejphar.2021.173919","journal-title":"Eur J Pharmacol"},{"key":"637_CR6","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman HM, Westbrook J, Feng Z et al (2000) The protein data bank. Nucleic Acids Res 28:235\u2013242. https:\/\/doi.org\/10.1093\/nar\/28.1.235","journal-title":"Nucleic Acids Res"},{"key":"637_CR7","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s11010-019-03617-5","volume":"462","author":"S Bhattacharya","year":"2019","unstructured":"Bhattacharya S, Patel KK, Dehari D et al (2019) Melatonin and its ubiquitous anticancer effects. Mol Cell Biochem 462:133\u2013155. https:\/\/doi.org\/10.1007\/s11010-019-03617-5","journal-title":"Mol Cell Biochem"},{"key":"637_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14051253","author":"M Bou Zerdan","year":"2022","unstructured":"Bou Zerdan M, Ghorayeb T, Saliba F (2022) Triple negative breast cancer: updates on classification and treatment in 2021. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers14051253","journal-title":"Cancers (Basel)"},{"key":"637_CR9","doi-asserted-by":"crossref","unstructured":"Bowers KJ, Chow E, Xu H et al (2006) Scalable algorithms for molecular dynamics simulations on commodity clusters. In: Proceedings of the 2006 ACM\/IEEE Conference on Supercomputing, SC\u201906. ACM Press, New York, New York, USA, p 84","DOI":"10.1145\/1188455.1188544"},{"key":"637_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2023.106644","volume":"155","author":"J Brahmbhatt","year":"2023","unstructured":"Brahmbhatt J, Kumar SP, Bhadresha K et al (2023) Targeting leukemic stem cell subpopulation in AML using phytochemicals: an in-silico and in-vitro approach. Comput Biol Med 155:106644. https:\/\/doi.org\/10.1016\/j.compbiomed.2023.106644","journal-title":"Comput Biol Med"},{"key":"637_CR11","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/s41568-019-0196-7","volume":"19","author":"JH Bushweller","year":"2019","unstructured":"Bushweller JH (2019) Targeting transcription factors in cancer \u2014 from undruggable to reality. Nat Rev Cancer 19:611\u2013624. https:\/\/doi.org\/10.1038\/s41568-019-0196-7","journal-title":"Nat Rev Cancer"},{"key":"637_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12020257","author":"C Cantonero","year":"2020","unstructured":"Cantonero C, Camello PJ, Abate C et al (2020) NO1, a new Sigma 2 receptor\/TMEM97 fluorescent ligand, downregulates SOCE and promotes apoptosis in the triple negative breast cancer cell lines. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers12020257","journal-title":"Cancers (Basel)"},{"issue":"Suppl 4","key":"637_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/1752-0509-8-S4-S11","volume":"8","author":"CH Chin","year":"2014","unstructured":"Chin CH, Chen SH, Wu HH (2014) CytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol 8(Suppl 4):S11. https:\/\/doi.org\/10.1186\/1752-0509-8-S4-S11","journal-title":"BMC Syst Biol"},{"key":"637_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-76024-2","author":"S Dashti","year":"2020","unstructured":"Dashti S, Taheri M, Ghafouri-Fard S (2020) An in-silico method leads to recognition of hub genes and crucial pathways in survival of patients with breast cancer. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-020-76024-2","journal-title":"Sci Rep"},{"key":"637_CR15","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.3390\/ijms14022410","volume":"14","author":"G Di Bella","year":"2013","unstructured":"Di Bella G, Mascia F, Gualano L, Di Bella L (2013) Melatonin anticancer effects: review. Int J Mol Sci 14:2410\u20132430. https:\/\/doi.org\/10.3390\/ijms14022410","journal-title":"Int J Mol Sci"},{"key":"637_CR16","doi-asserted-by":"publisher","first-page":"3828","DOI":"10.1002\/1878-0261.13319","volume":"16","author":"G Donati","year":"2022","unstructured":"Donati G, Amati B (2022) MYC and therapy resistance in cancer: risks and opportunities. Mol Oncol 16:3828\u20133854. https:\/\/doi.org\/10.1002\/1878-0261.13319","journal-title":"Mol Oncol"},{"key":"637_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0228062","volume":"15","author":"LC Ferreira","year":"2020","unstructured":"Ferreira LC, Orso F, Dettori D et al (2020) The role of melatonin on MiRNAs modulation in triple-negative breast cancer cells. PLoS ONE 15:1\u201315. https:\/\/doi.org\/10.1371\/journal.pone.0228062","journal-title":"PLoS ONE"},{"key":"637_CR18","doi-asserted-by":"publisher","first-page":"6177","DOI":"10.1021\/jm051256o","volume":"49","author":"RA Friesner","year":"2006","unstructured":"Friesner RA, Murphy RB, Repasky MP et al (2006) Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. J Med Chem 49:6177\u20136196. https:\/\/doi.org\/10.1021\/jm051256o","journal-title":"J Med Chem"},{"key":"637_CR19","doi-asserted-by":"publisher","first-page":"W234","DOI":"10.1093\/nar\/gkz240","volume":"47","author":"O Guangyan Zhou","year":"2019","unstructured":"Guangyan Zhou O, Soufan J, Ewald et al (2019) NetworkAnalyst 3.0: a visual analytics platform for comprehensive gene expression profiling and meta-analysis. Nucleic Acids Res 47:W234\u2013W241","journal-title":"Nucleic Acids Res"},{"key":"637_CR20","doi-asserted-by":"publisher","first-page":"28101","DOI":"10.18632\/oncotarget.15891","volume":"8","author":"N Gupta","year":"2017","unstructured":"Gupta N, Jung K, Wu C et al (2017) High Myc expression and transcription activity underlies intratumoral heterogeneity in triple-negative breast cancer. Oncotarget 8:28101\u201328115. https:\/\/doi.org\/10.18632\/oncotarget.15891","journal-title":"Oncotarget"},{"key":"637_CR21","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1021\/jm030644s","volume":"47","author":"TA Halgren","year":"2004","unstructured":"Halgren TA, Murphy RB, Friesner RA et al (2004) Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. J Med Chem 47:1750\u20131759. https:\/\/doi.org\/10.1021\/jm030644s","journal-title":"J Med Chem"},{"key":"637_CR22","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.2217\/pgs-2017-0117","volume":"18","author":"JR Jhan","year":"2017","unstructured":"Jhan JR, Andrechek ER (2017) Triple-negative breast cancer and the potential for targeted therapy. Pharmacogenomics 18:1595\u20131609. https:\/\/doi.org\/10.2217\/pgs-2017-0117","journal-title":"Pharmacogenomics"},{"key":"637_CR23","doi-asserted-by":"publisher","first-page":"11225","DOI":"10.1021\/ja9621760","volume":"118","author":"WL Jorgensen","year":"1996","unstructured":"Jorgensen WL, Maxwell DS, Tirado-Rives J (1996) Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids. J Am Chem Soc 118:11225\u201311236. https:\/\/doi.org\/10.1021\/ja9621760","journal-title":"J Am Chem Soc"},{"key":"637_CR24","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1093\/bioinformatics\/btq466","volume":"26","author":"A Lachmann","year":"2010","unstructured":"Lachmann A, Xu H, Krishnan J et al (2010) ChEA: transcription factor regulation inferred from integrating genome-wide ChIP-X experiments. Bioinformatics 26:2438\u20132444. https:\/\/doi.org\/10.1093\/bioinformatics\/btq466","journal-title":"Bioinformatics"},{"key":"637_CR25","doi-asserted-by":"publisher","DOI":"10.2196\/27633","author":"A L\u00e1nczky","year":"2021","unstructured":"L\u00e1nczky A, Gy\u0151rffy B (2021) Web-based survival analysis tool tailored for medical research (KMplot): development and implementation. J Med Internet Res. https:\/\/doi.org\/10.2196\/27633","journal-title":"J Med Internet Res"},{"key":"637_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/1748-717X-8-246","author":"T Lautenschlaeger","year":"2013","unstructured":"Lautenschlaeger T, Perry J, Peereboom D (2013) In vitro study of combined Cilengitide and radiation treatment in breast cancer cell lines. Radiat Oncol. https:\/\/doi.org\/10.1186\/1748-717X-8-246","journal-title":"Radiat Oncol"},{"key":"637_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-019-0700-2","author":"M Li","year":"2019","unstructured":"Li M, Li A, Zhou S (2019) Spag5 upregulation contributes to enhanced c-MYC transcriptional activity via interaction with c-MYC binding protein in triple-negative breast cancer. J Hematol Oncol. https:\/\/doi.org\/10.1186\/s13045-019-0700-2","journal-title":"J Hematol Oncol"},{"key":"637_CR28","doi-asserted-by":"publisher","DOI":"10.1177\/0300060520946169","author":"X Li","year":"2020","unstructured":"Li X, Tian R, Liu L et al (2020) Andrographolide enhanced radiosensitivity by downregulating glycolysis via the inhibition of the PI3K-Akt-mTOR signaling pathway in HCT116 colorectal cancer cells. J Int Med Res. https:\/\/doi.org\/10.1177\/0300060520946169","journal-title":"J Int Med Res"},{"key":"637_CR29","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1038\/s41388-022-02204-1","volume":"41","author":"Y Ma","year":"2022","unstructured":"Ma Y, Zhang H, Chen C et al (2022) TRIM32 promotes radioresistance by disrupting TC45-STAT3 interaction in triple-negative breast cancer. Oncogene 41:1589\u20131599. https:\/\/doi.org\/10.1038\/s41388-022-02204-1","journal-title":"Oncogene"},{"key":"637_CR30","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","volume":"27","author":"G Madhavi Sastry","year":"2013","unstructured":"Madhavi Sastry G, Adzhigirey M, Day T et al (2013) Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J Comput Aided Mol Des 27:221\u2013234. https:\/\/doi.org\/10.1007\/s10822-013-9644-8","journal-title":"J Comput Aided Mol Des"},{"key":"637_CR31","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1023\/A:1008763014207","volume":"18","author":"I Massova","year":"2000","unstructured":"Massova I, Kollman PA (2000) Combined molecular mechanical and continuum solvent approach (MM- PBSA\/GBSA) to predict ligand binding. Perspect Drug Discov Des 18:113\u2013135. https:\/\/doi.org\/10.1023\/A:1008763014207","journal-title":"Perspect Drug Discov Des"},{"key":"637_CR32","doi-asserted-by":"publisher","unstructured":"Mathur P, Sathishkumar K, Chaturvedi M et al (2020) Cancer Statistics, 2020: report from National cancer registry Programme, India. JCO Glob Oncol 1063\u20131075. https:\/\/doi.org\/10.1200\/go.20.00122","DOI":"10.1200\/go.20.00122"},{"key":"637_CR33","doi-asserted-by":"publisher","first-page":"209","DOI":"10.5306\/wjco.v13.i3.209","volume":"13","author":"R Mehrotra","year":"2022","unstructured":"Mehrotra R, Yadav K (2022) Breast cancer in India: present scenario and the challenges ahead. World J Clin Oncol 13:209\u2013218. https:\/\/doi.org\/10.5306\/wjco.v13.i3.209","journal-title":"World J Clin Oncol"},{"key":"637_CR34","doi-asserted-by":"publisher","first-page":"533","DOI":"10.25004\/ijpsdr.2023.150418","volume":"15","author":"D Mehta","year":"2023","unstructured":"Mehta D, Brahmbhatt J, Bhadresha K, Rawal R (2023) A review on biomarkers for predicting radioresistance and role of natural radiosensitizers in Triple-Negative breast cancer. Int J Pharm Sci Drug Res 15:533\u2013546. https:\/\/doi.org\/10.25004\/ijpsdr.2023.150418","journal-title":"Int J Pharm Sci Drug Res"},{"key":"637_CR35","doi-asserted-by":"publisher","first-page":"246","DOI":"10.14218\/ge.2023.00094","volume":"23(4)","author":"D Mehta","year":"2024","unstructured":"Mehta D, Prajapati J, Upadhyay V et al (2024) Exploring the role of seven key genes in breast cancer: insights from in silico and in vitro analyses. Gene Expr 23(4):246\u2013256. https:\/\/doi.org\/10.14218\/ge.2023.00094","journal-title":"Gene Expr"},{"key":"637_CR36","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0092-8674(02)01284-9","volume":"112","author":"SK Nair","year":"2003","unstructured":"Nair SK, Burley SK (2003) X-ray structures of Myc-Max and Mad-Max recognizing DNA: molecular bases of regulation by proto-oncogenic transcription factors. Cell 112:193\u2013205. https:\/\/doi.org\/10.1016\/S0092-8674(02)01284-9","journal-title":"Cell"},{"key":"637_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00031","author":"C Neophytou","year":"2018","unstructured":"Neophytou C, Boutsikos P, Papageorgis P (2018) Molecular mechanisms and emerging therapeutic targets of triple-negative breast cancer metastasis. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2018.00031","journal-title":"Front Oncol"},{"key":"637_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00827","author":"P Pearngam","year":"2019","unstructured":"Pearngam P, Kumkate S, Okada S, Janvilisri T (2019) Andrographolide inhibits cholangiocarcinoma cell migration by down-regulation of claudin-1 via the p-38 signaling pathway. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2019.00827","journal-title":"Front Pharmacol"},{"key":"637_CR39","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/pro.3943","volume":"30","author":"EF Pettersen","year":"2021","unstructured":"Pettersen EF, Goddard TD, Huang CC et al (2021) UCSF chimerax: structure visualization for researchers, educators, and developers. Protein Sci 30:70\u201382. https:\/\/doi.org\/10.1002\/pro.3943","journal-title":"Protein Sci"},{"key":"637_CR40","doi-asserted-by":"publisher","first-page":"W89","DOI":"10.1093\/nar\/gkx272","volume":"45","author":"JM Sagendorf","year":"2017","unstructured":"Sagendorf JM, Berman HM, Rohs R (2017) DNAproDB: an interactive tool for structural analysis of DNA-protein complexes. Nucleic Acids Res 45:W89\u2013W97. https:\/\/doi.org\/10.1093\/nar\/gkx272","journal-title":"Nucleic Acids Res"},{"key":"637_CR41","doi-asserted-by":"publisher","first-page":"D277","DOI":"10.1093\/nar\/gkz889","volume":"48","author":"JM Sagendorf","year":"2020","unstructured":"Sagendorf JM, Markarian N, Berman HM, Rohs R (2020) DNAproDB: an expanded database and web-based tool for structural analysis of DNA-protein complexes. Nucleic Acids Res 48:D277\u2013D287. https:\/\/doi.org\/10.1093\/nar\/gkz889","journal-title":"Nucleic Acids Res"},{"key":"637_CR42","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.cels.2018.03.003","volume":"6","author":"FX Schaub","year":"2018","unstructured":"Schaub FX, Dhankani V, Berger AC (2018) Pan-cancer alterations of the MYC oncogene and its proximal network across the cancer genome atlas. Cell Syst 6:282-300e2. https:\/\/doi.org\/10.1016\/j.cels.2018.03.003","journal-title":"Cell Syst"},{"issue":"D1","key":"637_CR43","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk D, Gable AL, Lyon D et al (2019) STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res 47(D1):D607\u2013D613. https:\/\/doi.org\/10.1093\/nar\/gky1131","journal-title":"Nucleic Acids Res"},{"key":"637_CR44","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s10549-022-06673-6","volume":"195","author":"M Tang","year":"2022","unstructured":"Tang M, O\u2019Grady S, Crown J, Duffy MJ (2022) MYC as a therapeutic target for the treatment of triple-negative breast cancer: preclinical investigations with the novel MYC inhibitor, MYCi975. Breast Cancer Res Treat 195:105\u2013115. https:\/\/doi.org\/10.1007\/s10549-022-06673-6","journal-title":"Breast Cancer Res Treat"},{"key":"637_CR45","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s10549-022-06533-3","volume":"193","author":"NH To","year":"2022","unstructured":"To NH, Nguyen HQ, Thiolat A et al (2022) Radiation therapy for triple-negative breast cancer: emerging role of microRNAs as biomarkers and radiosensitivity modifiers. A systematic review. Breast Cancer Res Treat 193:265\u2013279. https:\/\/doi.org\/10.1007\/s10549-022-06533-3","journal-title":"Breast Cancer Res Treat"},{"key":"637_CR46","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1146\/annurev.biophys.30.1.211","volume":"30","author":"W Wang","year":"2001","unstructured":"Wang W, Donini O, Reyes CM, Kollman PA (2001) Biomolecular simulations: recent developments in force fields, simulations of enzyme catalysis, protein-ligand, protein-protein, and protein-nucleic acid noncovalent interactions. Annu Rev Biophys Biomol Struct 30:211\u2013243","journal-title":"Annu Rev Biophys Biomol Struct"},{"key":"637_CR47","doi-asserted-by":"publisher","first-page":"287","DOI":"10.2174\/157340906778226454","volume":"2","author":"J Wang","year":"2006","unstructured":"Wang J, Hou T, Xu X (2006) Recent advances in free energy calculations with a combination of molecular mechanics and continuum models. Current Computer Aided-Drug Design 2:287\u2013306. https:\/\/doi.org\/10.2174\/157340906778226454","journal-title":"Current Computer Aided-Drug Design"},{"key":"637_CR48","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1074\/mcp.M113.029793","volume":"13","author":"J Wang","year":"2014","unstructured":"Wang J, Tan XF, Nguyen VS et al (2014) A quantitative chemical proteomics approach to profile the specific cellular targets of andrographolide, a promising anticancer agent that suppresses tumor metastasis. Mol Cell Proteomics 13:876\u2013886. https:\/\/doi.org\/10.1074\/mcp.M113.029793","journal-title":"Mol Cell Proteomics"},{"key":"637_CR49","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/s41388-018-0421-y","volume":"38","author":"E Wang","year":"2019","unstructured":"Wang E, Sorolla A, Cunningham PT et al (2019) Tumor penetrating peptides inhibiting MYC as a potent targeted therapeutic strategy for triple-negative breast cancers. Oncogene 38:140\u2013150. https:\/\/doi.org\/10.1038\/s41388-018-0421-y","journal-title":"Oncogene"},{"key":"637_CR50","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.202103090","author":"JR Whitfield","year":"2021","unstructured":"Whitfield JR, Soucek L (2021) The long journey to bring a Myc inhibitor to the clinic. J Cell Biol. https:\/\/doi.org\/10.1083\/jcb.202103090","journal-title":"J Cell Biol"},{"key":"637_CR51","doi-asserted-by":"publisher","first-page":"3232","DOI":"10.1093\/bioinformatics\/btt562","volume":"29","author":"J Xia","year":"2013","unstructured":"Xia J, Lyle NH, Mayer ML et al (2013) INVEX - A web-based tool for integrative visualization of expression data. Bioinformatics 29:3232\u20133234. https:\/\/doi.org\/10.1093\/bioinformatics\/btt562","journal-title":"Bioinformatics"},{"key":"637_CR52","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/nprot.2015.052","volume":"10","author":"J Xia","year":"2015","unstructured":"Xia J, Gill EE, Hancock REW (2015) Networkanalyst for statistical, visual and network-based meta-analysis of gene expression data. Nat Protoc 10:823\u2013844. https:\/\/doi.org\/10.1038\/nprot.2015.052","journal-title":"Nat Protoc"},{"key":"637_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-020-01296-5","author":"L Yin","year":"2020","unstructured":"Yin L, Duan JJ, Bian XW, Yu SC (2020) Triple-negative breast cancer molecular subtyping and treatment progress. Breast Cancer Res. https:\/\/doi.org\/10.1186\/s13058-020-01296-5","journal-title":"Breast Cancer Res"},{"key":"637_CR54","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1080\/13880209.2016.1176056","volume":"54","author":"H Yuan","year":"2016","unstructured":"Yuan H, Sun B, Gao F, Lan M (2016) Synergistic anticancer effects of Andrographolide and Paclitaxel against A549 NSCLC cells. Pharm Biol 54:2629\u20132635. https:\/\/doi.org\/10.1080\/13880209.2016.1176056","journal-title":"Pharm Biol"},{"key":"637_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-022-00468-0","author":"P Zagami","year":"2022","unstructured":"Zagami P, Carey LA (2022) Triple negative breast cancer: pitfalls and progress. NPJ Breast Cancer. https:\/\/doi.org\/10.1038\/s41523-022-00468-0","journal-title":"NPJ Breast Cancer"},{"key":"637_CR56","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1093\/carcin\/bgac008","volume":"43","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Wang C, Goel A (2022) A combined treatment with melatonin and andrographis promotes autophagy and anticancer activity in colorectal cancer. Carcinogenesis 43:217\u2013230. https:\/\/doi.org\/10.1093\/carcin\/bgac008","journal-title":"Carcinogenesis"},{"key":"637_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34000-6","author":"D Zimmerli","year":"2022","unstructured":"Zimmerli D, Brambillasca CS, Talens F et al (2022) MYC promotes immune-suppression in triple-negative breast cancer via inhibition of interferon signaling. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-022-34000-6","journal-title":"Nat Commun"}],"container-title":["Network Modeling Analysis in Health Informatics and Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13721-025-00637-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13721-025-00637-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13721-025-00637-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T06:11:33Z","timestamp":1762841493000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13721-025-00637-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,11]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["637"],"URL":"https:\/\/doi.org\/10.1007\/s13721-025-00637-8","relation":{},"ISSN":["2192-6670"],"issn-type":[{"value":"2192-6670","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,11]]},"assertion":[{"value":"18 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The conduct of this study was under the stringent approval and regular reviews of the Ethical Committee and Institutional Review Board, as indicated by Approval number GU\/IEC\/08\/2019, providing additional ethical assurance for this research undertaking.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"142"}}